Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F F Rutten

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Pharmacoeconomics|July 24, 2001
The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasisL Hakkaart-van Roijen, P Verboom, W K Redekop, et al.
Perceptual and Motor Skills|March 11, 2000
Factors to consider when designing phase III clinical trials involving economic evaluationsP J van Enckevort, E M TenVergert, J Kingma, et al.
International Journal of Technology Assessment in Health Care|January 1, 1996
Labor and health status in economic evaluation of health care. The Health and Labor QuestionnaireL van Roijen, M L Essink-Bot, M A Koopmanschap, et al.
Diseases of the Colon and Rectum|June 30, 1998
Cost-effectiveness of dynamic graciloplasty in patients with fecal incontinenceE M Adang, G L Engel, F F Rutten, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myelomaC A Uyl-de Groot, G J Ossenkoppele, A A van Riet, et al.
Headache|April 1, 1995
The impact of migraine on health statusM L Essink-Bot, L van Royen, P Krabbe, et al.
Lancet (London, England)|January 1, 2000
Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysisA J Goverde, J McDonnell, J P Vermeiden, et al.
Bone Marrow Transplantation|September 1, 1995
Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL)C A Uyl-de Groot, A Hagenbeek, L F Verdonck, et al.
British Journal of Haematology|April 8, 1998
Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukemiaC A Uyl-de Groot, B Löwenberg, E Vellenga, et al.
Pharmacoeconomics|September 8, 2000
Cost of illness in adult patients with hypopituitarismC Ehrnborg, L Hakkaart-Van Roijen, B Jonsson, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Pharmacoeconomics|July 24, 2001
The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasisL Hakkaart-van Roijen, P Verboom, W K Redekop, et al.
Perceptual and Motor Skills|March 11, 2000
Factors to consider when designing phase III clinical trials involving economic evaluationsP J van Enckevort, E M TenVergert, J Kingma, et al.
International Journal of Technology Assessment in Health Care|January 1, 1996
Labor and health status in economic evaluation of health care. The Health and Labor QuestionnaireL van Roijen, M L Essink-Bot, M A Koopmanschap, et al.
Diseases of the Colon and Rectum|June 30, 1998
Cost-effectiveness of dynamic graciloplasty in patients with fecal incontinenceE M Adang, G L Engel, F F Rutten, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myelomaC A Uyl-de Groot, G J Ossenkoppele, A A van Riet, et al.
Headache|April 1, 1995
The impact of migraine on health statusM L Essink-Bot, L van Royen, P Krabbe, et al.
Lancet (London, England)|January 1, 2000
Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysisA J Goverde, J McDonnell, J P Vermeiden, et al.
Bone Marrow Transplantation|September 1, 1995
Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL)C A Uyl-de Groot, A Hagenbeek, L F Verdonck, et al.
British Journal of Haematology|April 8, 1998
Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukemiaC A Uyl-de Groot, B Löwenberg, E Vellenga, et al.
Pharmacoeconomics|September 8, 2000
Cost of illness in adult patients with hypopituitarismC Ehrnborg, L Hakkaart-Van Roijen, B Jonsson, et al.
Pageof 9